1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 3: Identifiable SMA percentages compared across ROIs in patients with brain tumor
Target Group Percentage Identified (95% CI) Reference Group Percentage Identified (95% CI) P Valuea Hand Hand (both) Hand (right) 75.8 (63.4–85.1) 95.5 (86.4–98.8) <.001b Hand (left) 75.8 (63.4–85.1) 95.5 (86.4–98.8) <.001b Orofacial Orofacial (both) Orofacial (right) 25.8 (16.1–38.2) 34.8 (23.8–47.7) .074 Orofacial (left) 27.3 (17.4–39.8) 34.8 (23.8–47.7) .041 Hand (both) 95.5 (86.4–98.8) 34.8 (23.8–47.7) <.001b